cis-acting sequences required for class II gene regulation by interferon gamma and tumor necrosis factor alpha in a murine macrophage cell line by unknown
cis-ACTING SEQUENCES REQUIRED FOR CLASS II GENE
REGULATION BY INTERFERON y AND TUMOR NECROSIS
FACTOR a IN A MURINE MACROPHAGE CELL LINE
By YVONNE R. FREUND,' RUSSELL L. DEDRICK,I
AND PATRICIA P. JONES1
From the 'Department of Immunology and Infectious Diseases, Research Institute,
Palo Alto Medical Foundation, Palo'Alto, California 94301; and the
(Department of Biological Sciences, Stanford University, Stanford, California 94305
The class II genes ofthe mouse MHC encode four polypeptide chains that are
expressed as two heterodimers, the AcA0 and the EaEf molecules, on a restricted
numberofcell types. On thymic epithelial and dendriticcells, expression ofthe class
II (Ia) molecules is necessary for normal T cell maturation, and in the periphery,
cells expressing these molecules play acrucial role in theinitiation ofantigen-specific
immune responses.
la-expressing cells in the periphery include B cells, macrophages, dendritic cells,
and some epithelial and endothelial cells. Exogenous antigens must be processed
by these cells and presented in the context ofthe la molecules in order to be recog-
nized by the Th cell receptor. In light ofevidence that APC, in particular macro-
phages, internalize and process self, as well as foreign antigens (1), the requirement
for strict regulationofIa expression maybecritical to avoid presentation ofselfmol-
ecules, and triggering of autoimmune disease. Thus, on mouse macrophages, ex-
pression ofthe la molecules can be modulated by various cytokines and mediators
of inflammation.
The principal mediator ofIa induction is IFN-y, and the molecular mechanisms
by which this cytokine exerts its effect have been a subject ofgreatinterest (reviewed
in references 2 and 3). In murine and human cell lines, IFN-.y has been shown to
increase the expression ofclass II molecules in a coordinate manner (4, 5) and to
function primarilyby increasingratesoftranscription ofthese genes(6, 7). The struc-
tural basis for this coordinate regulation of transcription is likely to be due to the
sequence similarities in the 5' flanking regions of the class II genes; and these cis-
acting elements, with theircorresponding DNA-bindingproteins, arecurrentlybeing
intensively studied (8-17). Two conserved sequences, which have been designated
the X and Y boxes, are found 5' of the transcription initiation site in all class II
genes and havebeenshown tobe required for promoter activity (8, 9). Several inves-
tigators have proposed that the coordinate responses ofthe class II genes to various
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lymphokines may be mediated by the X and Y consensus regions (8, 10). 5' of the
X box is another conserved sequence called the heptamer sequence or the H box
(13, 14). The H box is included in a region that has been called the Z box in the
HLA-DRa gene (11) and the Wbox in the HLA-DQs gene (12). The Z box sequence
has been implicated in tissue-specific and IFN-y-inducible responsiveness (11), and
the Hbox, inIFN-y-specific induction (11, 15, 16). In a recent study(17), we demon-
strated that the H, X, and Y box elements ofthe Aa gene promoter are all required
for constitutive expression in B lymphoma cells and forIFN-y-inducible expression
in a myelomonocytic cell line.
TNFa, aproduct ofactivated macrophages, hasbeen shown to induce Ia surface
expression (18), as well as expression of other immunoregulatory molecules such
as IL-1 (19), IL-6 (20), and theIL-2-R (21). TNF-a frequently enhances the activity
ofIFN-y, andthe twocytokines act synergistically in the induction ofIa expression,
antiviral activity, and 2'5' oligoadenylate synthetase activity (22). TNF-a increases
la expression by increasing levels of mRNA for the Ia molecules (18); however, it
is not known whether it increases transcription or stabilizes the RNA. In this study,
we investigated theeffect ofTNFa onlagene expression inthe murine myelomono-
cyticcell line WEHI-3, in thepresence or absence ofIFN-y, andcompared itsmode
of action with that ofIFN-y. We found that both cytokines increase total mRNA
for the Aa gene and increase the activity ofthe Aa promoter. Mutational analysis
ofthis promoterhas revealed that TNFa-mediated induction requires all ofthe se-
quence elements that have been shown to be necessary for IFN-y-mediated induc-
tion. Furthermore, an additional sequence element was found to affect induction
by TNF-a, but not by IFN-y.
Materials and Methods
Cell Culture.
￿
WEHI-3, a myelomonocytic cell line derived from a BALB/c mouse (23),
was used inthese studies. CellswereculturedinRPMI 1640with 10% FCS (HyClone Labo-
ratories, Logan, UT), 5 x 10-5 M j3-mercaptoethanol, and penicillin-streptomycin (50 U/ml
and 50 jug/ml), and were screened monthly for mycoplasma infection.
Reagents.
￿
All cytokines used in this study were generously provided by Dr. M. Shepard,
Genentech, Inc. (South San Francisco, CA). Recombinant murine IFN-y, produced in Es-
cherichia coli, had a specific activity of 1.03 or 1.74 x 10' antiviral U/mg protein. Recombi
nant murine TNFa had a specific activity of 2.9 x 10-7 U/mg protein and
￿
0.125 EU/ml
of endotoxin, as assayed by the limulus amoebocyte lysate assay. '4C-chloramphenicol,
[dichloroacetyl-1,2-'4C] with a specific activity of 60.0 mci/mmol was obtained from New
England Nuclear (Boston, MA). Acetyl coenzyme A (sodium salt) was obtained from Sigma
Chemical Co. (St. Louis, MO); DEAE dextran, from Pharmacia LKB Biotechnology Inc.
(Piscataway, NJ) and n-Luciferin from Analytical Luminescence Laboratory (San Diego, CA).
mAbs.
￿
The following FITC-conjugated mAbs were used in this study: MK-D6 (anti-Ap)
(24), 10-3.6 (anti-As) (25), 14-4-4 (anti-E,,,) (26), and 34-1-2 (anti-H-2K', Dd) (27).
Measurement ofCell Surface la Expression.
￿
WEHI-3 cells were seeded at 2.5 x 105 cells per
60-mm tissue culture dish and treated for 48 h with IFN-y, TNF-a, or both cytokines. Max-
imal induction was observed using 10 or 20 U/ml IFN-.y and 1 nM TNFa. Cells were removed
from dishes by pipeting, then pelleted, resuspended in optimal amounts of FITC-conjugated
mAbs (1 jug antibody per sample), and incubated for 30 min at room temperature. Medium
used for the labeling was RPMI 1640 + 5 c/o FCS + 0.02% sodium azide. Cells were washed,
resuspended in medium containing propidium iodide at a final concentration of 1 tag/ml to
stain dead cells, and analyzed on an EPICS 753 flow cytometer (Coulter Electronics Inc.,
Hialeah, FL). The analyses in this study were gated to eliminate dead, propidium iodide-pos-FREUND ET AL.
itive cells, and scatter-gated to eliminate large, aggregated cells and debris. Staining with
10-3 .6 served as a control for nonspecific binding of antibody to Fc receptors.
Northern Blot Analysis.
￿
RNA was isolated from WEHI-3 cells treated for 48 h with IFN-'Y
(10 U/ml), TNFa (1 nM), or both cytokines at these concentrations, according to the method
ofChirgwin et al. (28). 10 gg oftotal RNA was subjected to electrophoresis in a 1.57o agarose-
formaldehyde gel, transferred onto Nytran nylon membrane (Schleicher & Schuell, Inc., Keene,
NH), and hybridized to an A,,, probe, as previously described (4). The probe was a 790-bp
Pst I cDNA fragment originally obtained from M. Davis (Stanford, CA), which was labeled
with 12P-dCTP by the hexamer priming method (29). Kodak X-AR5 x-ray film was
preflashed so that exposure of the film would be linearly related to radioactivity on the filter,
and films were exposed usingCronex Lightening Plus intensifying screens. Filmswere ana-
lyzed using an Ultro-scan XL laser densitometer (LKB Instruments, Inc., Gaithersburg, MD)
to quantitate increases in total mRNA.
Plasmid Construction.
￿
The pA' plasmid containing the genomic A« gene and ti5 kb of 5'
flanking sequence was generously provided by Dr. Leroy Hood (Pasadena, CA), and the pro-
moter region was identified and sequenced as described elsewhere (17). The plasmid pA,"
CAT 1, containing the A,, promoter region fused to the chloramphenicol acetyl transferase
(CAT)' reporter gene, was constructed by blunt-end ligating 2.5 kb of the A« promoter, using
the Barn HI site at position -1 and filling in with Klenow enzyme, to pAIOCAT2 (30) (gen-
erously provided by Dr. Jane Parnes, Stanford, CA), which had been digested with Hind
III and made blunt by filling in. The pAa CAT276 plasmid was constructed using an Sst
I-Bam HI fragment of pAa CAT 1 that extended from position -276 of the Aa promoter
through to the SV40 poly(A) site of the CAT reporter gene. This fragment was blunt-end
ligated into the Eco RI site of pUC18 so that the polylinker of pUC 18 was at the 5' end
of the A« sequence. The luciferase plasmid, pSV2ALA 5', was generously provided by Dr.
Suresh Subramani (La Jolla, CA).
Construction of5' Deletion Mutants.
￿
Mutants of the 5' region of the Aa promoter were con-
structed using Bal 31 exonuclease digestion of the 5' region of the pAa CAT-276 plasmid, as
previously described (17). A fragment of the Es gene was cloned into the Sma I site of the
PAq CAT-276 plasmid to protect the Xba I restriction site in the pUC18 polylinker from bi-
directional digestion by Bal 31, and aliquots of the reaction were terminated at various times.
The remaining Ep DNA was removed by Bam HI digestion and the plasmid ends were made
blunt with Klenow enzyme and ligated so that an intact Xba I site bordered the deletion
end-point. Constructs were characterized by sequencingusing the method of Sanger et al. (31).
Construction ofLinker-Scanner Mutants.
￿
The linker-scanner mutants were constructed as a
set of recombinant plasmids all containing the CAT gene and -276 by of the A« promoter,
starting from the site of transcription initiation. In each construct, a 12-bp piece of the pro-
moter region was replaced by linker sequences. These constructs were created by generating
paired 3' and 5' deletions and ligating pairs to create the mutation of interest. Generation
of the deletions that were used as the 3' end was described above. To generate the 5' ends,
the same principles were followed, except that mung bean nuclease, rather than Klenow en-
zyme, was used to blunt the ends ofthe deleted DNA before ligating. Fragments were ligated,
bacteria were transformed, and clones were screened for the amount of deleted DNA and
characterized by sequencing. 5' and 3' deletions were matched to generate sequential 12-bp
inserts spanning the first 173 by 5' from the A,,, initiation site. This procedure has been de-
tailed elsewhere (17). The resulting mutants were designated according to the most 5' and
most 3' nucleotides altered relative to the initiation site.
Transfection.
￿
WEHI-3 cells were transfected with 12.5 Ag of the pAo , CAT DNA and 2 .5
Ag of luciferase DNA using DEAE dextran (32). Briefly, WEHI-3 cells were seeded at 3 x
106 cells/100-mm plate, 16-18 h before transfection. The medium was removed, and 3 ml
of RPMI containing 10 jig/ml of DEAE dextran and DNA was added to each plate. Cells
were incubated for 4 h at 37°C, shocked for 2 min with 10% DMSO in RPMI, washed,
pooled, and replated so that promoter activity could be assayed in cells treated with: (a) no
' Abbreviation used in this paper. CAT, chloramphenicol acetyl transferase.
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cytokines; (b) 20 U/ml IFN-1'; (c) 1 nM TNFa; or (d) both cytokinesat theseconcentrations.
Transfection with the pUC18 plasmid was used as a control for endogenous CAT activity.
In this case, no luciferase gene was cotransfected, and these extracts were also used to mea-
sure background activity in the luciferase assay.
Luciferase and CATEnzyme Assays.
￿
Luciferase activity was assayed on 20 JAI of cell extract
from transfected cells that had not been treated with cytokines, according to the method of
deWet et al. (33), using a Monolight 2001 luminometer. Cell extracts were then heated to
60°C for 7 min (34), and CAT activity was measured accordingto Gorman et al. (35), using
' 4C-choramphenicol. Acetylated products were separated by TLC and visualized by auto-
radiography. Quantitative measurements were obtained by cutting out the acetylated spots
and measuring radioactivity in a scintillation counter. Promoter activity was determined by
subtracting the values obtained from the pUC18 control transfectants from each sample's
'4C counts and luciferase activity; then dividing counts by luciferase activity to normalize
fortheamount ofDNAthat wastransfected into each sample. When data from several exper-
iments were compared, the induction of CAT activity using the mutant constructs was ex-
pressed as a percent of the induction using the full-length construct.
DNASequence Comparisons.
￿
TheIFINDandALIGNprograms from IntelliGenetics (Moun-
tain View, CA) were used to search the Genbank/EMBL Data Bank for sequenceswith ho-
mology to unique elements in the A' . promoter. These programs are based on the algorithm
developed by Wilbur and Lipman (36).
Results
IFN-yandTNF-aIncrease Cell SurfaceExpression oftheI-A andtheI-EProteins.
￿
WEHI-3
cellswere cultured for48 hwith either 20 U/ml IFN-'Y, 1 nM TNFa, or a combina-
tion of the two cytokines, and surface expression of the I-A or I-E proteins was ana-
lyzed (Fig. 1). Uninduced WEHI-3 cells expressed essentially no surface I-A or I-E
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FIGURE 1.
￿
Fluorescence histograms of I-A and
I-E antigen expression on murine WEHI-3 cells
induced with IFN-,y, TNFa, or both lympho
TNF-a
￿
kines. Cells were treated with 20 U/ml IFN-,
y, I
nM TNFa, or both for48 h, then stained with
the following FITC-conjugated mAbs: MK-D6
(anti-A,), 14-4-4 (anti-E.,), or 10-3 .6 (anti-Aok),
andanalyzed on an Epics753flow cytometer. All
data were obtained in thesame representative ex-
periment. A25-channel change represents adou-
bling in fluorescence intensity. Dark lines repre-
sent I-Aor I-Eantigen expression when induced
IFN-Y +TNF-a
￿
by thecytokines, thin solidlinesrepresent expres-
sion in uninduced cells, and dashed lines repre-
sent staining of the cells with antibody to lak,
which measures nonspecific staining. The latter
has been included only in the left-hand panels.
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molecules . Both IFN-1' andTNFa induced class II antigen expression on the ma-
jority ofcells after a 48-h exposure . TNFa induction of both I-A and I-E molecules
was bimodal, indicating that there were two distinct populations of cells that could
be induced to express either higher or lower levels of these molecules . This bimodal
induction was not a function of the dose of TNF-a administered, since cells were
treated with TNFa in a dose range between 0.5 and 50 nM for48 h, and no further
shift in the population was observed at doses >1 nM (data not shown) . In addition,
when cells cultured for 24 h were compared with cells cultured for 48 h, an almost
identical pattern of bimodality was observed . As shown in the lower panels of Fig .
1, when WEHI-3 was treated for 48 h with both IFN-y andTNFa, all of the cells
strongly expressed I-A andI-Eantigens, indicating that the addition ofthe twocyto-
kines together was able to convert more cells to the highly positive phenotype than
addition of TNFa alone.
The Induction ofI-A and I-E Cell Surface Expression Occurs through an Increase inmRNA .
￿
To
determine the effect ofIFN-y on AamRNA levels, RNA was isolated from treated
cells and analyzed by Northern blot hybridization (Fig. 2) . Therewas no detectable
message fortheAc , gene product in uninduced cells . Treatment with IFN-1' induced
AamRNA, and treatment with TNF-a induced Aa mRNA to even higher levels .
Densitometric analysis of theautoradiograms indicated that when cellswere induced
with both IFN-y and TNFa, levels of Aa message were three- to fourfold greater
than when cells were induced with either cytokine alone . These results demonstrated
that Ia surface expression is accompanied by an increase in levels of mRNA .
Both IFN-y and TNF-a Increase Activity oftheAa Promoter .
￿
We had previously de-
FIGURE 2 .
￿
Northern blot analysis ofRNA from WEHI-3 cells
treated for 48 hwith (lane 1) medium, (lane 2) IFN-y at 10 U/ml,
(lane 3) TNRa at 1 nM, and (lane 4) both cytokines. 10 tLg of
total RNA was subjected to electrophoresis in a 1.5% agarose-
formaldehyde gel and hybridized to a s2P-labeled cDNA probe for
theA« gene . The locations of the 28 and 18S ribosomalbands are
indicated. Densitometric analysis of the intensity of the band in
each lane was as follows (in absorbance units x mm): lane 1, 0 ;
lane 2, 0.78; lane 3, 1.26 ; and lane 4, 3.74 .1288 SEQUENCES REQUIRED FOR CLASS II GENE REGULATION
FwURE 3 . Autoradiogram of CAT
activity in extracts fromWEHI-3 cells
transfected with pAd dCAT 1 after treat-
ment with IFN-,y and/orTNFa . Lanes
1 and 2 show CAT activity in extracts
from mock transfected cells (noDNA) .
Lane 3 contains extracts from cells not
treated with cytokines ; lane 4, from
cells treated with 20 U/ml of IFN-y ;
lane 5, from cells treated with 1 nM
TNF-a ; and lane 6, from cells treated
with both cytokines . Cells in lanes 7
and 8 were transfected with the
pA~CAT 1 construct in the reverse ori-
entation (pAdCAT 2) and either not
treated with cytokines (lane 7), or
treated with IFN-y (lane 8) . Lane 9
contains CAT enzyme as a positive
control .
termined, using nuclear run-on experiments, that the increase in AamRNA after
IFN-y treatment ofWEHI-3 cells was due to an increase in the rate oftranscription
of the Aa gene (7) . To determine the effect of IFN- ,y and TNFa on the activity of
a class II promoter, we fused the Aa promoter to the bacterial CAT reporter gene .
Promoter activity was measured by assaying CAT activity. When theCAT gene was
fused to theAa promoter with 2.5 kb of 5' flanking DNA, CAT activity in WEHI-3
cells was induced by both IFN-,y andTNFa (Fig . 3, lanes 3-6) . Mock transfected
cells (no DNA; Fig. 3, lanes 1 and 2) and cells transfected with the CAT construct
in the reverse orientation (lanes 7and 8) showed no CAT activity. A similar pattern
of induction was obtained using pA«CAT276, which contained only 276 by of the
5' flanking sequence. This indicated that -276 by of 5' flanking sequence was sufficient
to confer inducibility, although we have not ruled out the possibility that additional
regulatory elements existbetween -276 and -2 .5 kb . We have alsoshownthatwhen
pAa CAT-276 was transfected into L cells, which do not express la, or into consti-
tutively expressing B cell lymphomas, the relative CAT activity reflected the Ia phe-
notype of the recipient cell (17) .
105 by of5 Sequence Are RequiredforAa Promoter Inducibility by IFN-y or TNF-a .
￿
To
determine howmuch of the 276-bp 5' sequence was critical for induction by TNF-a,
we used aseries of 5' deletion mutants . The 5' ends of these deletions are illustrated
by the circled numbers in Fig . 4 . These mutantswere transfected into WEHI-3 cells,
and the effects of IFN-,y andTNFa on CAT expression were determined (Fig . 5) .
Data were corrected for the efficiency of transfection, usingluciferase activity as pre-
viously described in Materials and Methods, and results were expressed as relative
CAT activity. Aswas observed with IFN-y-mediated induction, response to TNF-a
alone was eliminated when the promoter region was deleted to <105 by 5' of the
initiation site .H BOX
FREUND ET AL .
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2 BOX
￿
NO ENHANCER
FIGURE 4 .
￿
Nucleotide sequence
of the promoter region of the
murineAagene from positions
-169 to -1 (17). The circled,
bold-faced numbers below the se-
quence indicate the 5' end points
ofthe deletion mutations . The
Z, H, X, andYbox homologies
X BOX
￿
are indicated by boxed areas in
-too
￿
I -90
￿
-a0
￿
-7o
￿
i
￿
.50
￿
theAc, sequence. Stippled boxes
TAATACAAAGCCTGC GCTGGCAACGGTG
￿
TCACCACAAGGGAATTT
￿
indicate the KB-like enhancerre-
"
￿
gion residues and the Tbox res-
idues . The arrow represents the
position of the transcription
start sites . The linker-scanner
mutations are indicated by
boxes below the sequence that
span the regionsaltered byeach
YBOX
￿
T BOX
￿
mutation . Linker-scanner mu
-ao
￿
-ao
￿
-20
￿
-10
￿
+1
￿
tations replaced the regions be-
tween the mutation endpoints
with the following linker se-
quence: GATCCTCTAGAG .
Three Sequences in the Region between -126 and the Initiation SiteAreRequiredfor Induction
ofCATActivity by Both IFN-yand TNF-a . To define regulatory sequence elements
in more detail, we created a series of nested linker-scanner mutations covering the
region of -173 to -5, altering sequential 12-bpportions of the promoter. The boxes
in Fig . 4 illustrate the regions of the Aa promoter altered by the various linker-
FIGURE 5.
￿
Effect of 5' deletions of the Aa promoter on
CAT expression in WEHI-3 cells by IFN--y,TNRa, or both
cytokines. Data are averages from four experiments, ex-
pressed as relativeCAT activity ± SEM and corrected for
transfection efficiency by assaying for luciferase activity (see
Materialsand Methods) . Deletions without SEMwere as-
sayed once .1290
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FicURE 6 .
￿
Data from a representative transfection exper-
iment, showing results ofthe CAT assay on extracts from
WEHI-3 cells transfected with selected linker-scanner con-
structs. Data are expressed as relative CAT activity, indi-
cating that they have been corrected for transfection
efficiency by assaying for luciferase activity.
scanner mutants, andvariation from the wild-type sequence is described in the figure
legend . Fig. 6 shows results from one such experiment, using selected constructs
that showed the most pronounced effects on IFN-y andTNFa induction . The data
show that two linker-scanner mutations resulted in nearly total loss ofpromoter ac-
tivity in the presence ofcytokines : LS[ - 55,-42], which alters theY box, and LS[- 75,
-62], which covers the 3' end of theXbox (see Fig. 4) . Severalother linker-scanner
mutations also reduce induction by the cytokines . Fig. 7 summarizes data from six
experiments . The results have been normalized to the amount of induction seen
with the wild-type plasmid in each experiment . Thiswasdone to facilitate averaging
of results from several experiments, since induced levels of Ia andCAT expression
varied from one experiment to the next . The vertical line at 1.0 represents CAT ac-
tivity when cells were transfected usingthe wild-type pAd ~CAT276 and treated with
a particular cytokine . The analysis shows that three mutant constructs consistently
decreased promoter inducibility to 25% or less of that obtained with the full-length
construct . Two of these are the constructs that alter theY box (LS[-55,-42]) and
the 3' end of the X box (LS[-75,-62]) . The third alters the 5' end of the X box
(LS[-86,-73]) . Two other mutations also consistently decreased the induction by
both IFN-y andTNFa . These were LS[-112,-99], which encompasses the H box
described by Servenius et al . (13) and Thanos et al . (14), and LS[-126,-115], which
covers -a region homologous to the KB enhancer of the Ig genes (37). Each of these
mutations had similar effects on induction by IFN-y, TNFa, or by both cytokines .
Finally, the only sequence found to be uniquely important for induction by one cy-
tokine and not by the other is the sequence altered by LS[-31,-18] . This alteration
decreases, but does not eliminate, TNFa responsiveness; however, it has no effect
on induction by IFN-y. (see Figs . 6 and 7) . Alteration of this sequence also reduces
CAT transcription in cells treated with both cytokines .
In summary, linker-scanner analysis has revealed three sequences that are crit-
ical, and one that appears to be important, for optimal induction by both IFN-yA
LS[-173,-1611
LS[-164i-1511
LSE-155,-1411
LS[-141,1281
LS[-126,1151
LS[-119,1071
LS[-112,991
LS[-102,-891
LS[-86,-731
LS[-75,-621
LS[-63,501
LS[-55,-421
LS[-39,271
LS[-31,-181
LS[-18,51
0.0 0 .5
LS[-173,1611
LS[-164,1511
LS[-155,-1411
LS[-141,-1281
LS[-126,-1151
LS[-119,1071
LS[-112,991
LS[-102,-891
LS[-86,731
LS[-75,62]
LS[-63;501
LS[-55,-421
LS[-39,-271
LS[-31,181
LS[-18,5]
0.0 0 .5
IFN
1 .0 1 .5 2.0 2 .5
CAT ACTIVITY NORMALIZED TO INTACT
pAQCAT-276
IFN & TNF
1 .0 1l5 2 .0 2 .5
CAT ACTIVITY NORMALIZED TO INTACT
pAQCAT-276
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FIGURE 7 .
￿
Summary ofdata from six transfection
experiments using linker-scanner mutations. Panels
represent treatment with : (A) 20 U/ml IFN-y, (B)
1 nMTNFa, or(C) both cytokines, respectively. In-
duction for each construct has been expressed as a
fraction of the amount of induction obtained using
the full-length construct, pAqCAT276, to facilitate
averaging data from several experiments. Average in-
duction using pAaCAT276 is indicated by the ver-
tical line at 1.0 on the x-axis . Error bars represent
SEM. Constructs for which no error bars areshown
were assayed once .
and TNFa . These are the X, Y, and H boxes, and the KB enhancer. In addition,
a sequence between -31 and -18 appears to be important for optimal induction
byTNFa but notby IFN-y . No sequences appear to be uniquely required forIFN-y
induction .1292 SEQUENCES REQUIRED FOR CLASS II GENE REGULATION
Discussion
The murine class II MHC molecules, I-A and I-E, can be induced on the surface
ofthe WEHI-3 macrophage cell line by both IFN-y and TNFa. We have demon-
strated that IFN-y induces I-A and I-E expression on virtually all cells, andTNFa
induces a bimodal increase in the expression of both molecules. When IFN-'r and
TNFa are administered together, all ofthe cells become strongly I-A and I-Eposi-
tive. The basis for this synergy is not known, but could reflect effects of IFN-y on
TNF-a receptors, as has been demonstrated in human cells (38-40). Both IFN-y
and TNF-a exert their effect on class II expression by increasing levels of mRNA.
Northern blot analysis of mRNA from cells treated with both IFN-'r and TNFci
demonstrated that the combination ofthe two cytokines was twice as stimulatory
as if the effects of each cytokine had been added together. This synergy has also
been observed by Chang and Lee (18). The increase in mRNA levels occurs prima-
rily via an increase in transcription ofthe Ac, gene, since nuclear run on assays (7;
and our unpublished results) detected no transcription ofthe class II genes without
induction by IFN-y or TNFa.
We have examined sequences 5' of the Aa transcription initiation site to deter-
mine whether IFN-y and TNFat require identical or distinct sequences to activate
the A« promoter. These results confirm and extend our recent findings on Aa pro-
moter expression in B lymphoma cells and in IFN-y-induced WEHI-3 cells (17).
Mutational analysis demonstrated that sequences 3' of residue -105 were essential
forinduction by IFN-y andTNFa. Induction by eachindividual cytokine dropped
significantly when the promoter was deleted from -115 to -105, removing part of
the Hbox, and wascompletely abolished on deletion to -89, completely removing
the H box. Although induction by each individual cytokine was lost on deletion to
-105, inductionby both cytokines together was stillevidentwhen the promoterwas
deleted to -78. It appears that residues between -105 and -78 allow some syner-
gistic induction but are not sufficient for induction by the individual cytokines. A
better understanding ofthis observation will require analysis ofproteins binding
to this DNA region after induction or activation by the two cytokines individually
and in combination.
Analysis usinglinker-scanner mutationsindicated that the conserved class II pro-
moter elements are required for induction by both cytokines. Mutation of the Y
box (LS[-55,-42]) andthe Xbox(LS[-75,-62] and LS[-86,-73]) caused decreases
of 75% or more in induction by IFN-y or TNFa, when compared with induction
using the full-length (-276) construct. Mutation ofthe Hbox (LS[-112,-99]) also
resulted in a 75% decrease in IFN-y induction and a slightly smaller decrease in
TNFa induction. The Y boxis an inverted CCAATboxbetween residues -48 and
-39, with the sequence CTGATTGGTT, which is a perfect match with the con-
sensus Y box sequence (5) and is critical for A« promoter activity. Binding of nu-
clear proteins to the Y box has been extensively investigated in human and mouse
class 11 genes (8, 9, 12, 17, 41-43), and itis currently believed that only one protein,
a ubiquitous CCAAT box binding protein, NFY, binds to this box (9). No unique
Y box binding protein is induced by IFN-y, since a comparison ofIFN--y-induced
and -uninduced macrophages revealed no differences in Y box binding factors (8,
17, 43).FREUND ET AL.
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LS[-75,-62] and LS[-86,-73]) alter the3'and 5' ends ofthe Xbox, respectively,
and result in a major loss in promoter activity. The X box ofthe Aa promoter di-
verges more substantially from the consensus X box sequence than X boxes found
in other class II genes (17, 43), and it appears that a variety ofXbox binding pro-
teins may exist that are specific for the various la genes (43). Binding ofproteins
to the X box ofAa has been shown to be independent of cell type or lymphokine
stimulation (17, 43); therefore, although the Xbox is critical for promoter activity,
it may mediate IFN-y- or TNFa-specific induction only in the context of other,
more specific cis-acting sequences.
Linker-scanner mutation LS[-112,-99] spans an H boxelement containedwithin
residues -106 to -100, which matches the consensus Hbox sequence ofRRAYCTT
(13). Alteration ofthis sequence causes aloss in IFN-y-induced CAT expression and,
to a lesser extent, in CAT expression induced by TNFci or by IFN-y and TNFa
in combination. The H box is conserved in all ofthe la genes, as well as in several
human genes (13, 15). In the human DRa (15) and DQ (16) genes, sequences in
the area ofthe H box have been shown to be necessary, but not sufficient for IFN-'r
induction. We have demonstrated that this sequence is not uniquely required for
IFN-y inducibility, since it also appears to contribute to induction by TNFa. In
addition, the Hbox has been shown to beimportant for expression of the Aa pro-
moter in constitutively la-positive B cell lines (17).
In addition to the X, Y, and H elements, linker scanner analysis has implicated
two sequences, whose alteration decreased promoter activity by-50-60%. LS[-126,
-115] resulted in decreases in both IFN-y and TNFa induction. The region be-
tween residues -129 and -118 shows homology with theKB coreenhancersequence
found in the Ig is L chain. The consensus sequence is AGGGANT4 C7 )CAC (44). KB-
like enhancer elements are also found in the H-2Kb, 02-microglobulin, HIV-1 and
-2, human IL-2, and the IL-2-R achain genes(45). The IL-2-R a chain and HIV-1
KB-like enhancers have been the subject ofintense interest recently, in part because
both are transcriptionally regulated by TNFa (44, 46, 47). The KB-like enhancers
from both ofthesegenes arecapableofconferring TNFa inducibility toaheterolo-
gous promoter, and selective deletion ofthis sequence abrogates TNFciinducibility
inprimaryhumanTcellsas wellas inJurkat cells(44). The most recent DNA binding
studies revealed two proteins binding to the enhancer in the IL-2-R after stimula-
tion with TNFa: an 86-kD protein that corresponds to the HIVEN86A protein,
(anuclearprotein thatbinds the HIV-1 LTR, [48]), and a 51-kDprotein corresponding
to NFKB. Induction by TNFa also requires binding of several constitutively ex-
pressed factors to one upstream and two downstream sequences (44). These addi-
tional sequences are not present in the Aa promoter; however, this pattern of in-
duction may be a model for the function of TNFci in the Ac, promoter, in that
bindingtothe KB-like enhancer is important but not sufficient forinduction, without
the concomitant binding ofconstitutively expressed'fattorsto other sequences. While
the KB element of the Aa promoter seems to influence induction by IFN-y and
TNFa, it is intriguing that some induction still occurs when this element had been
removed by 5' deletions.
A final sequence element appears to play a role in transcription induced byTNF
a, but not by IFN-y. We have tentatively called this sequence, which spans residues
from -31 to -17, the T box, and have indicated its location in Figs. 4 and 8. The1294
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boundaries ofthiselement were assigned onthebasis ofhomologies with three mam-
malian sequencesdiscovered, in part, by a search oftheGenbank/EMBL Data Bank.
These sequences have been aligned in Fig. 8. A perfect homology to the Tbox se-
quence is found in the HLA-Do gene and a 14/15-bp match is found in the rat
RT1.Ba gene. These genes are the human and rat homologues of the murine A~
chain (49, 50). When the three genes are aligned so that there is maximum nucle
otide identity in the Y box and T boxes, an 11-bp insert is observed at the 3' end
of the HLA-DQ Y box. In the rat Bc, gene, the 3' portion of the T box includes
a TGTAA (TATA) box that is present in approximately the same position in both
the Ea gene and in the human homologue, HLA-DR,,,, but not present in the Aa
or HLA-DQ genes.
The full T box sequence is not found in the E« or the HLA-DRc, genes. How-
ever, as illustrated in Fig. 8 A, mouse E« and human DR,, share with Ac, the
TGNTTTG sequence in the center of the T box. It is possible that this 7-bp se-
quence may be sufficient to mediate the effect ofTNFa, since it is homologous to
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FIGURE 8.
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(A)Alignmentof aportion of the5' upstream sequence of theAa gene with sequences
from human HLA-DQa, rat RT1.Ba, murine Ea, and HLA-DRa. Sequence of HLA-DQ~ are
from Jonssonet al. (49), RT1.Bc , from Barran and McMaster (50), Ea from Mathis et al. (62),
andHLA-DRafrom Daset al. (63). Boxesidentify the Y boxand theTbox. Dots indicate iden-
tity when compared with the corresponding base in the murine Ac, sequence. Nucleotide se-
quences in each gene corresponding to the consensus core enhancer elements areshown in bold
type. (B)Alignment of the 5' upstream regions of the Ac, gene with the rat c-myc gene and the
core transcription enhancer elements found in SV40 virus, the HLA-DRa first intron, and Ig
w H chain. TheTbox sequencesin Ac,andc-mycare indicated, andthe core consensusdescribed
by Weiher (51) is shown. Sequences of rat c-mycare from Hayashi et al. (56) and of u H chain
are from Gillies et al. (53).FREUND ET AL.
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the core transcription enhancer described by Weiher (51) and observed in SV40,
polyoma virus, Ig, and the HLA-DR« genes (3, 51-53). The consensus sequence
for this enhancer is TGGAna~-r
,G, where the first G has been shown to be absolutely
required for enhancer activity (51). We have indicated the core transcription en-
hancer sequence in bold letters in each of the sequences in Fig. 8. In all genes, the
critical first G is present in the sequence. It is of interest to note that there are no
sequences corresponding to the T box, or to the SV40 core enhancer, in the pro-
moter regions of either the mouse A# and ES genes (see sequences in references 54
and 55), indicating that there may potentially be differential regulation of a and
(3 chains of the class II genes by TNFa.
A search of the Genbank/EMBL Data Bank revealed strong homology of the T
box sequence to a 15-bp region in the second intron of the rat, mouse, and human
c-mycgenes (56-58). Regulation ofclass Il genes, as well as thec-mycgene by TNFa,
could be mediated either via the core transcription element or via this larger region
ofhomology. TNFa has been foundto downregulate transcription of the c-mycgene
in the human promyelocytic leukemia cell line, HL-60 (59), and in HeLa cells (60).
Sequences responsible for this regulation have not been located, however, it is likely
that they are not in the 5' flanking region (61). It is intriguing to speculate that this
regulation involves the T box-like element in the second intron of the c-myc gene.
Evaluation of the significance of the T box sequence in the A« gene and its role
in TNF-a responsiveness will await determination of whether TNFa responsive-
ness can be transferred to a heterologous promoter by this element, and whether
proteins in extracts from TNFa-treated cells bind the Tbox andother core elements.
In conclusion, this analysis of cis-acting sequences has led to the followingmodel
for the transcriptional activation of the A« gene in WEHI-3 cells. At least four 5'
sequences are necessary for optimal induction by both IFN-'f and TNFa: the X,
Y, and H boxes and the KB-like enhancer. In addition, a sequence between -31
and -17, which we have designated the T box and which contains homology to the
core enhancer sequence, appears to be important for induction by TNFa . Having
delineated the cis-acting sequences required for activation by IFN-'y and TNFa,
it appears that to understand transcriptional activation of the Ac , gene, and of other
class II genes, it will be necessary to identify the proteins bindingto allof thecritical
cis-acting sequences and to determine whether bindingto one region influences binding
to another.
Summary
In this report, we have demonstrated that IFN-y and TNFa increase expression
of both the I-A and I-E region gene products on the surface of the myelomonocytic
cell line WEHI-3, and that they mediate this increase via an increase in A« tran-
scription. Constructs containing 5' deletion mutations ofthe Ac, promoter attached
to the bacterial chloramphenicol acetyl transferase gene were used to delineate the
minimum 5' flanking sequences required for promoter activity, and for inducibility
by IFN-y and TNFa. Approximately 115 by of 5' sequences are required for min-
imum induction by IFN-y or TNFce when the cytokines are presentseparately. This
includes the three conserved promoter elements, the X, Y, and H boxes. Nested
linker-scanner mutations demonstrated that additional regions were also critical for
optimal induction by IFN-,y or TNFa . These include the KB-like enhancer and a1296 SEQUENCES REQUIRED FOR CLASS II GENE REGULATION
TNFa-specific sequence that we have tentatively called the T box. The T box se-
quence was also found in the promoter regions of the human HLA-DQP , and rat
RT1.Ba genes . Although the entire T box sequence element was not found in the
other mouse class II genes, all class II a genes contained the SV40 core enhancer
element in the regions included by the T box. Mouse class 11 0 genes appear to
contain neither the T box nor the core enhancer element in this region, suggesting
differential regulation of class II a and a genes by TNFa .
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